Fig. 1. Effect of arctigenin on the viability of cancer cell lines. Cells were treated with an indicated dose of arctigenin for 24 hours and cell viability was measured by WST assay. (A) AGS. (B) MCF-7 (ER+, PR–, HER2–). (C) MDA-MB-231 (ER–, PR–, HER2–). (D) SK-BR-3 (ER–, PR–, HER2+). Results from duplicate experiments were analyzed by Student’s t-test (**P < 0.01 and ***P < 0.001). ER, estrogen receptor; PR, progesterone receptor; HER, human epidermal growth factor receptor 2.
© 2024 Biomed Sci Letters